Table 3.
Baseline Characteristics of US Adults Meeting the Definition for Hypertension According to the ACC/AHA Guideline, 2014 Expert Panel Report, and JNC7 Based on the 2013 to 2016 PINNACLE Registry Data
| Characteristics | ACC/AHA guideline | 2014 Report | Difference between ACC/AHA guideline and 2014 report | JNC7 | Difference between ACC/AHA guideline and JNC7 |
|---|---|---|---|---|---|
| Total No. | 5 027 961 | 4 521 272 | 506 689 | 4 545 976 | 481 985 |
| Age, y | |||||
| Mean±SD | 65.0±14.7 | 66.3±13.9 | 53.4±16.9 | 66.3±13.9 | 52.4±16.7 |
| Median (Q1–Q3) | 67.0 (56.0–76.0) | 67.0 (58.0–76.0) | 54.0 (41.0–66.0) | 68.0 (58.0–76.0) | 53.0 (40.0–65.0) |
| Range (minimum–maximum) | 18.0–100.0 | 18.0–100.0 | 18.0–100.0 | 18.0–100.0 | 18.0–100.0 |
| 18–44 | 9.5 | 7.1 | 31.0 | 7.1 | 32.6 |
| 45–54 | 12.6 | 11.8 | 19.7 | 11.7 | 20.7 |
| 55–64 | 21.9 | 22.0 | 21.1 | 22.0 | 21.2 |
| 65–74 | 28.3 | 29.5 | 17.4 | 29.6 | 15.9 |
| ≥75 | 27.6 | 29.5 | 10.8 | 29.6 | 9.5 |
| Sex | |||||
| Men | 50.3 | 50.8 | 46.2 | 50.7 | 46.3 |
| Women | 49.7 | 49.2 | 53.8 | 49.3 | 53.7 |
| Race | |||||
| White | 64.7 | 64.4 | 67.5 | 64.5 | 67.3 |
| Black | 7.5 | 7.6 | 6.5 | 7.6 | 6.6 |
| Other * | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Missing | 27.3 | 27.5 | 25.5 | 27.5 | 25.7 |
| History of stroke/TIA | 10.9 | 11.5 | 5.9 | 11.4 | 5.8 |
| History of stroke | 8.5 | 8.9 | 4.9 | 8.8 | 4.9 |
| History of TIA | 3.4 | 3.7 | 1.4 | 3.7 | 1.4 |
| Coronary artery disease | 38.3 | 41.4 | 10.7 | 41.2 | 10.5 |
| History of MI | 9.1 | 9.9 | 2.3 | 9.8 | 2.3 |
| History of PCI | 13.0 | 14.1 | 2.9 | 14.1 | 2.9 |
| History of CABG | 6.5 | 7.1 | 1.2 | 7.1 | 1.2 |
| Diabetes | 22.4 | 24.0 | 7.8 | 23.9 | 8.2 |
| Chronic kidney disease | 3.9 | 4.3 | 0.6 | 4.3 | 0.6 |
| Heart failure | 15.1 | 16.3 | 4.7 | 16.2 | 4.7 |
| 10‐y Predicted ASCVD risk, % | |||||
| Mean±SD (N) | 14.0±12.0 (82 765) | 14.8±12.3 (73 227) | 7.8±7.7 (9538) | 14.8±12.3 (73 548) | 7.6±7.5 (9217) |
| Median (Q1–Q3) | 10.6 (4.8–20.0) | 11.5 (5.4–21.1) | 5.3 (2.3–10.7) | 11.5 (5.4–21.1) | 5.0 (2.3–10.4) |
| Range (minimum–maximum) | 0.0–95.1 | 0.0–95.1 | 0.1–63.1 | 0.0–95.1 | 0.1–63.1 |
| <5 | 26.1 | 23.2 | 48.3 | 23.1 | 49.7 |
| 5–<10 | 21.9 | 21.6 | 24.3 | 21.6 | 24.1 |
| 10–<20 | 27.1 | 28.1 | 19.1 | 28.1 | 18.6 |
| ≥20 | 24.9 | 27.1 | 8.3 | 27.1 | 7.6 |
| History of CVD | 47.7 | 51.2 | 17.0 | 51.0 | 16.8 |
Data are given as percentages, unless otherwise indicated. ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic CVD; CABG, coronary artery bypass grafting; CVD, cardiovascular disease; JNC7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; MI, myocardial infarction; PCI, percutaneous coronary intervention; Q1, quartile 1; Q3, quartile 3; PINNACLE, Practice Innovation and Clinical Excellence; and TIA, transient ischemic attack.
*Defined as combination of any race other than White or Black, including Asian, American Indian/Alaskan Native, Native Hawaiin/Pacific Islander.